CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The CATACLIS project aims to revolutionize cell therapies for solid cancers by developing treatments based on patient-specific characteristics. It focuses on using patient-derived models to create tailored cellular products, addressing challenges such as tumor access and immune suppression in cancer treatment.
Cellular therapies are commonly used to treat hematological cancers but have yet to be established in solid oncology.
Their evolution has been fuelled by hypotheses derived from cell biological observations in cancer models.
Most approaches, however, will either never enter clinical development or fail clinical testing, often due to inadequate models of disease and their lack of relevance to human biology.In CATACLIS, I propose the first unbiased development of cellular products based on patient…
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Munchen
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
